Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

First Series C tranche brings $4.6mm to Neuroptix

Executive Summary

Inventages led a group of six investors in the $4.6mm Series C financing for Neuroptix Corp. (developing a biomarker in tandem with a laser device that scans the eye for early signs of Alzheimer’s disease). Another tranche worth approximately $3.4mm is payable when certain milestones are reached. The money will help advance the company’s Sapphire II platform through clinical studies.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Laser
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies